Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: 21 - What They Never Told You

Pfizer (PFE): Pre-Earnings Strategies

Pfizer (PFE) is facing hurdles due to weakened demand for its products and pipeline diversification challenges. Nevertheless, the company exhibits long-term potential through strategic acquisitions. Given this scenario, what course of action should be considered ahead of the upcoming earnings release? Read more to find out.

StockNews.com · Jan 29, 2024

More Than 150 Infants, Pregnant Women Given Incorrect RSV Vaccine, CDC Says

According to reports, there have been 25 cases of accidental administration of Pfizer (Abrsyvo) or GSK (Arexvy) RSV vaccines to children below two and 128 cases of mistaken administration of the GSK RSV vaccine (Arexvy) to pregnant women.

Medical Daily · Jan 24, 2024

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Kiplinger · Jan 18, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology

The Guardian - UK · Jan 16, 2024

CES 2024: How Tony Stark Can Save Pro AV (and Other Trends)

Artificial intelligence, electrification, hydrogen power, sustainability, human security, and mobility dominated the show floor.

AVNetwork · Jan 15, 2024

DEI opponents are using a 1866 Civil Rights law to challenge equity policies in the workplace

Opponents of diversity programs are increasingly banking on an 1866 civil rights law meant to protect Black people from economic exclusion as a way to challenge corporate diversity and equity policies as well as funding to Black-owned businesses

The Independent UK · Jan 14, 2024

As legal challenges mount, some companies retool diversity and inclusion programs

Conservative advocates have filed a growing number of legal challenges, encouraged by the Supreme Court’s June ruling ending affirmative action in college admissions

The Independent UK · Jan 14, 2024

Read news from The Economist, FT, and more,
with one subscription

FDA allows imports of French syphilis drug alternate during US penicillin shortage

While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted U.S. health officials to recommend giving some patients another antibiotic that requires of weeks of twice-daily pills.

Fortune · Jan 10, 2024

A Biochemist Reveals The One Tech That Could Revolutionize Drug Discovery

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

Inverse · Jan 9, 2024

Breathtaking BioNTech Projections Reveal Revenue Rebound by 2025!

BioNTech envisions a bright future as it predicts a revival in revenue growth by 2025. Get ready for a thrilling comeback that will reshape the biotech lan...

US faces ‘tragic’ rise in syphilis cases with life-saving drug in short supply

Incidence of serious sexually transmitted disease at 27-year high and demand for preferred antibiotic is straining manufacture

The Guardian - US · Jan 5, 2024

Florida Surgeon General's Claims on COVID Vaccines Debunked as Nonsense

Explore the debunked claims made by the Florida State Surgeon General regarding COVID vaccines and the integration of contaminants into DNA in this insight...

‘Scientific nonsense’: experts dismiss Florida official’s Covid vaccine remarks

State’s politically appointed surgeon general claims vaccines can contaminate human DNA but experts say comment has no merit

The Guardian - US · Jan 4, 2024

Drugs of the future will be easier and faster to make, thanks to mRNA – after researchers work out a few remaining kinks

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

The Conversation · Jan 4, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger · Jan 2, 2024

Drugmakers to Hike Prices on 500 Drugs Soon — Report

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

Barchart · Jan 2, 2024

Where Will Pfizer Stock Be in 1 Year?

PFE is a beaten-down healthcare stock that trades at a discount to consensus price target estimates. Is Pfizer stock a good buy right now?

The Independent UK · Dec 29, 2023

Men Up review: Viagra drama is a sweet tale of bonding in the face of shared misfortune

Thin characterisation and a slightly preachy message hold this 90-minute film back, but its heart is in the right place

StockNews.com · Dec 29, 2023

Pfizer (PFE) 2024 Preview: What to Expect From the Pharma Stock?

As Pfizer (PFE) navigates a post-pandemic world with a shifting focus away from COVID-related products, what should investors expect from this pharma giant? Let’s look at its financial metrics to know more….

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Dec 29, 2023

Inside Men Up – the Viagra drama determined to get men talking

The writer and stars of the brilliant BBC One film tell Katie Rosseinsky about delving into the origins of a drug that is so often associated with a punchline, but has irrevocably changed many people’s lives

International Business Times · Dec 19, 2023

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

The Conversation · Dec 18, 2023

mRNA COVID vaccines make 'unintended proteins' – we've discovered how to fix this problem

MRNA, a type of genetic material that provides the instructions your cells need in order to make proteins, used to be a term mainly used by scientists. But since COVID arrived many of us are now familiar with it thanks to the mRNA-based vaccines.

Evening Standard · Dec 17, 2023

Men Up: what's the true story behind the BBC's new drama about the first Viagra trials in Wales?

In 2021, impotence affected as many as 16.5 million men in the UK; 50 per cent of the male population. But how many of them talked about it? To their friends, even to their partners? Men have always been tight-lipped about their problems – health problems even more so, and those…

Barchart · Dec 14, 2023

I’ve Got 5 Stocks and 5 DTEs: Which Call Should I Buy?

Wednesday’s unusual options activity had multiple stocks with two or more calls expiring on the same day. Five stocks caught my interest. Only one of the calls is worth buying.

International Business Times · Dec 13, 2023

Pfizer Shares Tumble On Disappointing 2024 Profit Outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

Pfizer's 2024 Revenue Forecast Fails to Meet Wall Street Expectations

Amid a dismal financial outlook for 2024 and falling sales of COVID-19 products, Pfizer shares see a 7% tumble triggering Wall Street worries.

1 … 20 21 22 23

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.